• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Sinopharm Group (OP: SHTDY )

    12.96 -0.35 (-2.60%)
    Streaming Delayed Price Updated: 10:58 AM EDT, Jul 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,018
    Open 12.97
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 13.31
    Today's Range 12.95 - 12.98
    52wk Range 11.36 - 16.31
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Current Analysis: Sinopharm Group
    Sinopharm Group Co. Ltd. was founded in 2003 and listed on the Hong Kong Stock Exchange in September 2009. Over the past year, Sinopharm’s share price rose about 20% from $10.26 to $12.36 as of... 
    Via Talk Markets
    Week In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's Neuca
    China’s drug distributors are in the hunt to acquire Poland’s Neuca, a company with a 32% market share of Poland’s pharmaceutical distribution business. The consortium of China’s drug distributors may... 
    Via Talk Markets

    Performance

    YTD
    +1.08%
    +1.08%
    1 Month
    -4.77%
    -4.77%
    3 Month
    -0.73%
    -0.73%
    6 Month
    +1.69%
    +1.69%
    1 Year
    -13.10%
    -13.10%

    More News

    Read More
    Daily Stock Analysis: Sinopharm Group
    Via Talk Markets
    Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It
    Via Benzinga
    UK Trial On Mix-Match COVID-19 Vaccines Expanded To Add Moderna, Novavax Shots
    Via Benzinga
    Exposures COVID-19
    South African Variant Able To Elude Pfizer/BioNTech' Vaccine Protection, Israeli Study Shows: Report
    Via Benzinga
    Exposures COVID-19
    Government, Officials Defend AstraZeneca's COVID-19 Shot: CNBC
    Via Benzinga
    Exposures COVID-19
    Europe's Drug Watchdog Concludes Possible Link Between AstraZeneca COVID-19 Vaccine And Blood Clots
    Via Benzinga
    Exposures COVID-19
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.